Dyadic International (DYAI) Competitors $1.71 +0.01 (+0.36%) (As of 11:19 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DYAI vs. MDWD, LFVN, CABA, ZURA, SCPH, PROC, HRTX, TIL, ADAP, and VTYXShould you be buying Dyadic International stock or one of its competitors? The main competitors of Dyadic International include MediWound (MDWD), LifeVantage (LFVN), Cabaletta Bio (CABA), Zura Bio (ZURA), scPharmaceuticals (SCPH), Procaps Group (PROC), Heron Therapeutics (HRTX), Instil Bio (TIL), Adaptimmune Therapeutics (ADAP), and Ventyx Biosciences (VTYX). These companies are all part of the "pharmaceutical products" industry. Dyadic International vs. MediWound LifeVantage Cabaletta Bio Zura Bio scPharmaceuticals Procaps Group Heron Therapeutics Instil Bio Adaptimmune Therapeutics Ventyx Biosciences Dyadic International (NASDAQ:DYAI) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Which has higher earnings & valuation, DYAI or MDWD? MediWound has higher revenue and earnings than Dyadic International. Dyadic International is trading at a lower price-to-earnings ratio than MediWound, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyadic International$2.90M17.41-$6.80M-$0.23-7.42MediWound$19.72M10.11-$6.72M-$2.90-6.38 Which has more volatility and risk, DYAI or MDWD? Dyadic International has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Does the MarketBeat Community believe in DYAI or MDWD? MediWound received 233 more outperform votes than Dyadic International when rated by MarketBeat users. However, 64.40% of users gave Dyadic International an outperform vote while only 62.15% of users gave MediWound an outperform vote. CompanyUnderperformOutperformDyadic InternationalOutperform Votes16164.40% Underperform Votes8935.60% MediWoundOutperform Votes39462.15% Underperform Votes24037.85% Do analysts rate DYAI or MDWD? Dyadic International currently has a consensus price target of $6.00, suggesting a potential upside of 251.68%. MediWound has a consensus price target of $27.50, suggesting a potential upside of 48.73%. Given Dyadic International's higher probable upside, research analysts plainly believe Dyadic International is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00MediWound 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor DYAI or MDWD? In the previous week, MediWound had 9 more articles in the media than Dyadic International. MarketBeat recorded 12 mentions for MediWound and 3 mentions for Dyadic International. Dyadic International's average media sentiment score of 0.96 beat MediWound's score of 0.14 indicating that Dyadic International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MediWound 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in DYAI or MDWD? 28.0% of Dyadic International shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 28.8% of Dyadic International shares are held by company insiders. Comparatively, 9.2% of MediWound shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is DYAI or MDWD more profitable? MediWound has a net margin of -142.29% compared to Dyadic International's net margin of -188.09%. MediWound's return on equity of -82.17% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Dyadic International-188.09% -149.16% -59.81% MediWound -142.29%-82.17%-33.67% SummaryMediWound beats Dyadic International on 10 of the 17 factors compared between the two stocks. Ad Darwin"Start Earning Extra Income with Just $30"What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYAI vs. The Competition Export to ExcelMetricDyadic InternationalBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.48M$3.09B$5.20B$8.97BDividend YieldN/A1.84%5.23%4.04%P/E Ratio-7.4215.2685.7113.39Price / Sales17.41315.091,469.4286.49Price / CashN/A175.8435.2935.09Price / Book8.534.044.914.96Net Income-$6.80M-$41.68M$117.36M$224.10M7 Day Performance-1.38%6.57%2.75%2.01%1 Month Performance60.95%5.81%1.71%9.79%1 Year Performance-3.61%38.20%36.01%29.97% Dyadic International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYAIDyadic International2.6556 of 5 stars$1.71+0.4%$6.00+251.7%-4.0%$50.48M$2.90M-7.427Short Interest ↓Gap UpMDWDMediWound1.6409 of 5 stars$18.10+3.6%$27.50+51.9%+104.5%$195.30M$18.69M-6.0280Analyst RevisionLFVNLifeVantage3.7184 of 5 stars$15.11+3.7%N/A+138.8%$189.18M$200.16M45.66260Positive NewsGap UpCABACabaletta Bio3.4253 of 5 stars$3.82+26.9%$26.25+587.2%-74.2%$186.71MN/A-1.7850Gap UpHigh Trading VolumeZURAZura Bio3.243 of 5 stars$2.85-6.6%$15.80+454.4%-41.4%$186.08MN/A0.003SCPHscPharmaceuticals4.0281 of 5 stars$3.71+2.5%$15.00+304.3%-32.4%$185.65M$13.59M-1.9130Positive NewsPROCProcaps Group0.8389 of 5 stars$1.64+8.6%N/A-37.4%$185.03M$414.10M3.275,500Gap UpHRTXHeron Therapeutics4.0401 of 5 stars$1.22+2.1%$5.67+366.4%-7.6%$184.80M$127.04M-6.67300Positive NewsGap UpTILInstil Bio3.6131 of 5 stars$28.28+5.1%$145.00+412.7%+301.5%$184.67MN/A-2.5449Short Interest ↓Positive NewsADAPAdaptimmune Therapeutics2.0622 of 5 stars$0.72-0.1%$2.79+287.2%+33.4%$184.23M$60.28M-3.36449Short Interest ↑VTYXVentyx Biosciences3.4949 of 5 stars$2.56-4.5%$10.00+290.6%+14.5%$181.02MN/A-1.1073Positive News Related Companies and Tools Related Companies MediWound Alternatives LifeVantage Alternatives Cabaletta Bio Alternatives Zura Bio Alternatives scPharmaceuticals Alternatives Procaps Group Alternatives Heron Therapeutics Alternatives Instil Bio Alternatives Adaptimmune Therapeutics Alternatives Ventyx Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DYAI) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyadic International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
